Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Apr 19, 2023
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Pine Pharmaceuticals, LLC
FDA (openFDA drug enforcement)
Reported Apr 19, 2023
Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40);…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sun Pharmaceutical Industries Inc.
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Accord Healthcare, Inc.
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Azurity Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Direct Rx
2 more products in this recall
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
19 more products in this recall
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.RemedyRepack Inc.
13 more products in this recall
FDA (openFDA drug enforcement)
Reported Apr 12, 2023
Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Teva Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Apr 5, 2023
Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Apollo Care
FDA (openFDA drug enforcement)
Reported Apr 5, 2023
Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Ascend Laboratories, LLC
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Apr 5, 2023
Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Direct Rx
10 more products in this recall
FDA (openFDA drug enforcement)
Reported Apr 5, 2023
Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Endo Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Mar 29, 2023
JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Boehringer Ingelheim Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Mar 29, 2023
Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.) tube, Distributed…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Global Pharma Healthcare Private Limited
FDA (openFDA drug enforcement)
Reported Mar 29, 2023
Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Noven Pharmaceuticals Inc.
3 more products in this recall
FDA (openFDA drug enforcement)
Reported Mar 29, 2023
Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sun Pharmaceutical Industries Inc.
FDA (openFDA drug enforcement)
Reported Mar 22, 2023
Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only,…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.AVEVA Drug Delivery Systems, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Mar 22, 2023
Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c)…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Breckenridge Pharmaceutical, Inc.
5 more products in this recall
FDA (openFDA drug enforcement)
Reported Mar 22, 2023
Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Padagis US LLC
FDA (openFDA drug enforcement)
Reported Mar 22, 2023
Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Mar 22, 2023
Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Zydus Pharmaceuticals (USA) Inc.
FDA (openFDA drug enforcement)
Reported Mar 15, 2023
DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Akron Pharma, Inc.
FDA (openFDA drug enforcement)
Reported Mar 15, 2023
Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Amerisource Health Services LLC
FDA (openFDA drug enforcement)
Reported Mar 15, 2023
Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1, UPC 3…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Apotex Corp.
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.